ArticleEuropean journal of medical research2025

Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study.

Bangbei Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.